USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen
Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Notably, the deployment of ZTE's FDD Massive MIMO (FMM) products on Bitel's live network has increased user experience ...
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
Acer today expanded its line of Chromebook offerings for education with three new laptops plus one tablet model, all with ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...
The Express Tribune on MSN18h
PTA outlines below-par performance of mobile firmsPakistan Telecommunication Authority (PTA) has highlighted the poor performance of cellular mobile operators (CMOs) in areas of network coverage, broadband, voice and SMS services.Based on compliance ...
South Central Railway (SCR) enhancing infrastructure with Kavach & LTE technology, achieving 100% electrification, and ...
During the 76th Republic Day parade in Kolkata, the Indian Army’s robotic dogs, ‘MULE’, demonstrating their advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback